相关实验视频

Updated: Sep 20, 2025

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

聚合性免疫球蛋白受体 (pIgR) 在癌症进展中:关键作用和潜在的治疗点

Shaoju Qian^1,2,3, Yeqing He¹, Ruixue Li⁴

¹School of Basic Medical Sciences, Xinxiang Medical University, #601 Jinsui Road, Xinxiang, 453003, Henan, People's Republic of China.

Apoptosis : an international journal on programmed cell death

|May 25, 2025

概括

聚合物免疫球蛋白受体 (pIgR) 在免疫和癌症中起着关键作用. 准pIgR为癌症治疗提供了有前途的新策略,特别是与现有治疗相结合时.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

聚合物免疫球蛋白受体 (pIgR) 对于免疫球蛋白传输和免疫调节至关重要.
在各种癌症中,人们越来越认识到pIgR的失调,这会影响诊断和预后.
pIgR在癌症中的作用是复杂的,其机制和影响取决于环境.

研究的目的:

审查pIgR在癌症中的多方面的作用.
探索针对pIgR进行癌症治疗的新兴治疗策略.
讨论基于pIgR的癌症治疗中的挑战和未来方向.

主要方法:

关于癌症中的pIgR研究的文献综述.
在不同类型的癌症中分析pIgR的机制.
对针对pIgR的当前和潜在治疗干预措施的评估.

主要成果:

作为癌症诊断和预后的生物标志物,pIgR具有显著的临床价值.
治疗策略包括二维IgA方法,小分子调节器 (例如,布法林) 和基于抗体的EV-pIgR向.
组合疗法,如EV-pIgR阻塞与传统治疗或dIgA向与免疫疗法,显示增强的疗效.

结论:

pIgR是一个有前途的新兴治疗点,用于新型癌症治疗.
进一步了解pIgR调节机制对于优化向疗法至关重要.
将pIgR向策略与现有治疗方法相结合,有可能改善癌症患者的治疗结果.

关键词:

癌症的发展癌症的发展癌症免疫疗法癌症免疫疗法调节失调是一种失调.聚合性免疫球蛋白受体的受体预测生物标志物预测生物标志物

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: